Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This entry refers to a category of molecular pathways rather than a specific molecular target. Paracrine signaling via growth factors, cytokines, and extracellular vesicles is fundamental in mediating cell communication across short distances in tissues[5][1][7]. These pathways regulate critical biological processes including cell proliferation, differentiation, inflammation, tissue repair, neuroprotection, angiogenesis, inhibition of apoptosis, and wound healing[1][3][2][4][7]. Growth factors and cytokines are soluble proteins that bind specific cell surface receptors, triggering intracellular signaling cascades to elicit physiological changes. Extracellular vesicles (EVs) are membrane-bound nano- to micron-scale particles released by cells that deliver bioactive cargo—including proteins, lipids, RNA, and signaling mediators—to recipient cells, directly affecting their function and phenotype[2][4][8]. These mechanisms play roles in cancer biology, inflammatory and immune responses, neurodegeneration, cardiovascular pathologies, and other disease states, but do not correspond to a unique therapeutic target; rather, they comprise a complex signaling network with wide-ranging clinical relevance and therapeutic opportunity. This entry is incorrect as a target because it refers to multiple classes and mechanisms rather than a singular, canonical therapeutic molecule or receptor. For structured target information, further specification of a unique molecule or receptor (e.g., Fibroblast growth factor receptor, Interleukin-6 receptor, Epidermal growth factor receptor) is required[1][3][5].
Ligand-receptor interaction; Activation of receptor tyrosine kinase pathways (e.g., MAP kinase, PI3K, Ral pathway); Uptake and cargo delivery via extracellular vesicles; Modulation of immune and inflammatory responses
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Multiple Paracrine Signaling Pathways.